Category Public health

The antiviral Remdesivir reduces recovery time in COVID-19 patients

On 29 April, Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases (NIAID), announced that a clinical trial in more than 1,000 people had showed that those taking remdesivir recovered in 11 days on average, compared with 15 days for those on a placebo. There were also fewer deaths among trial participants who received the drug, he said, but that trend was not statistically significant. The shortened recovery time, however, was significant.

Documents regarding classification of death due to COVID-19

The WHO guidelines: “This document describes certification and classification (coding) of deaths related to COVID-19. The primary goal is to identify all deaths due to COVID-19.” The CDC (USA) guidelines: “The purpose of this report is to provide guidance… Continue Reading →

Newer posts »

© 2024 — Powered by WordPress